GLP-1 receptor agonists are a class of prescription medications originally developed for type 2 diabetes and now clinically recognised for their ability to support weight management in appropriate patients
Sletved KSO, Ziersen SC, Andersen PK, Vinberg M, Kessing LV
Los pacientes pueden experimentar una sensacin de mareo o somnolencia, lo que puede afectar su capacidad para realizar actividades diarias
To avoid an adverse reaction, please obtain advice from your medical practitioner if you are pregnant/breastfeeding, have a medical condition, or are taking any medication
Therefore, during DUL treatment, we should pay close attention to the related signs of pancreatitis, and if pancreatitis occurs, we need to stop the drug immediately (113)